Company B & S Pharm Srl with Fiscal Code 18090189
recorded a turnover of 2024 of
18.375,
with a net profit of
-8.612
and having an average number of employees of
1.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
B & S Pharm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
141.390
141.147
152.422
17.510
0
0
0
0
104.628
18.375
Total Income - EUR
141.392
141.150
152.425
17.687
89
0
0
0
104.628
18.401
Total Expenses - EUR
134.280
132.468
143.534
22.548
1.970
3.165
3.050
18.795
104.219
27.014
Gross Profit/Loss - EUR
7.112
8.682
8.891
-4.861
-1.881
-3.165
-3.049
-18.795
410
-8.612
Net Profit/Loss - EUR
5.277
7.148
7.321
-5.038
-1.884
-3.165
-3.049
-18.795
320
-8.612
Employees
3
3
2
1
1
0
0
0
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -82.3%, from 104.628 euro in the year 2023, to 18.375 euro in 2024.
The Net Profit decreased by -318 euro, from 320 euro in 2023, to 0 in the last year.
Check the financial reports for the company - B & S Pharm Srl
Financial Rating - B & S PHARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - B & S Pharm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - B & S Pharm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - B & S Pharm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
B & S Pharm Srl - CUI 18090189
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
3.136
3.649
1.961
503
409
160
0
0
0
0
Current Assets
72.608
65.692
72.135
24.172
25.040
25.711
25.104
10.949
75.200
39.742
Inventories
20.463
23.151
21.084
15.774
15.469
15.184
14.847
2
1.915
3.157
Receivables
21.112
12.610
30.045
6.099
8.728
9.630
10.145
10.819
68.875
31.676
Cash
31.032
29.930
21.006
2.299
843
898
111
128
4.410
4.910
Shareholders Funds
27.710
12.308
12.898
7.623
5.591
2.320
-781
-19.578
-19.198
-27.703
Social Capital
45
45
88
86
84
83
81
81
81
80
Debts
48.034
57.044
61.210
17.053
19.857
23.552
25.884
30.526
94.449
67.467
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
39.742 euro in 2024 which includes Inventories of
3.157 euro, Receivables of
31.676 euro and cash availability of
4.910 euro.
The company's Equity was valued at
-27.703 euro, while total Liabilities amounted to
67.467 euro.
Equity decreased by -8.612 euro, from -19.198 euro in 2023, to -27.703 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - B & S Pharm Srl